Skip to main content
Medicine logoLink to Medicine
. 2019 Mar 8;98(10):e14869. doi: 10.1097/MD.0000000000014869

Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report: Erratum

PMCID: PMC6417611  PMID: 30855513

In the article, “Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report”,[1] which appeared in Volume 96, Issue 51 of Medicine, “PDMSCs hydrogel (cell number: 1 × 10^6/cells/cm2)” should be written as “PDMSCs hydrogel (cell number: 1 × 10^6/cells/ml).”

Reference

  • [1].Zeng X, Tang Y, Hu K. Three-week topical treatment with placenta-derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer: A case report. Medicine. 2017. 96:e9212. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES